Micronesia, Federated States of vs North Macedonia: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage
Micronesia, Federated States of
74.0%
in 2024
North Macedonia
72.0%
in 2024
Micronesia, Federated States of rank
118th
North Macedonia rank
121st
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage over time
- Micronesia, Federated States of
- North Macedonia
How they compare
Micronesia, Federated States of currently reports 74.0% against 72.0% in North Macedonia, a difference of 2.0%.
Across all 5 years both countries report, Micronesia, Federated States of has been ahead every year.
Micronesia, Federated States of ranks 118th and North Macedonia ranks 121st of 146 countries.
Micronesia, Federated States of has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage, Micronesia, Federated States of or North Macedonia?
- Micronesia, Federated States of, at 74.0% against 72.0% in North Macedonia as of 2024.
- What is the difference in pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage between Micronesia, Federated States of and North Macedonia?
- 2.0%, with Micronesia, Federated States of ahead.
- How many years of comparable data are there for Micronesia, Federated States of and North Macedonia?
- 5 years are reported by both, from 2020 to 2024.
- How do Micronesia, Federated States of and North Macedonia rank globally for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Micronesia, Federated States of ranks 118th and North Macedonia ranks 121st of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.